(Q38000415)

26 August 2017

title

IFN-α and TRAIL: a double edge sword in HIV-1 disease? (English)

1 reference

26 August 2017

Marie-Lise Gougeon

1

1 reference

26 August 2017

Jean-Philippe Herbeuval

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

26 March 2012

1 reference

Experimental Cell Research

26 August 2017

published in

1 reference

26 August 2017

volume

318

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

1260-1268

1 reference

Plasmacytoid dendritic cells in immunity

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV‐1 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Apoptosis as an HIV strategy to escape immune attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Antigen crosspresentation by human plasmacytoid dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Glycerol monolaurate prevents mucosal SIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

The nature of the principal type 1 interferon-producing cells in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Early Plasmacytoid Dendritic Cell Changes Predict Plasma HIV Load Rebound during Primary Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I interferons in host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I IFN modulates innate and specific antiviral immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

HIV-1 immunopathogenesis: how good interferon turns bad.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Multiple effects of interferon on the replication of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells reduce HIV production in elite controllers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Measles virus induces functional TRAIL production by human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Nature's TRAIL--on a path to cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

The TRAIL to viral pathogenesis: the good, the bad and the ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

TRAIL-R as a negative regulator of innate immune cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Rapid disease progression in HIV-1-infected men who have sex with men is negatively correlated with peripheral plasmacytoid dendritic cell counts at the early stage of primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Chronic innate immune activation as a cause of HIV-1 immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Plasmacytoid dendritic cells in HIV infection: striking a delicate balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.012

10.1016/J.YEXCR.2012.03.012

7 January 2021

Identifiers

DOI

1 reference

release_fccytldgkffc7mmaswdos47lam

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fccytldgkffc7mmaswdos47lam

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference